• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞质 DROSHA 和 FLT3-ITD 急性髓系白血病 miR-155 生物发生的非经典机制。

Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.

机构信息

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, CA, USA.

Department of Immuno-Oncology, City of Hope Medical Center, Duarte, CA, USA.

出版信息

Leukemia. 2021 Aug;35(8):2285-2298. doi: 10.1038/s41375-021-01166-9. Epub 2021 Feb 15.

DOI:10.1038/s41375-021-01166-9
PMID:33589748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8973317/
Abstract

We report here on a novel pro-leukemogenic role of FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) that interferes with microRNAs (miRNAs) biogenesis in acute myeloid leukemia (AML) blasts. We showed that FLT3-ITD interferes with the canonical biogenesis of intron-hosted miRNAs such as miR-126, by phosphorylating SPRED1 protein and inhibiting the "gatekeeper" Exportin 5 (XPO5)/RAN-GTP complex that regulates the nucleus-to-cytoplasm transport of pre-miRNAs for completion of maturation into mature miRNAs. Of note, despite the blockage of "canonical" miRNA biogenesis, miR-155 remains upregulated in FLT3-ITD+ AML blasts, suggesting activation of alternative mechanisms of miRNA biogenesis that circumvent the XPO5/RAN-GTP blockage. MiR-155, a BIC-155 long noncoding (lnc) RNA-hosted oncogenic miRNA, has previously been implicated in FLT3-ITD+ AML blast hyperproliferation. We showed that FLT3-ITD upregulates miR-155 by inhibiting DDX3X, a protein implicated in the splicing of lncRNAs, via p-AKT. Inhibition of DDX3X increases unspliced BIC-155 that is then shuttled by NXF1 from the nucleus to the cytoplasm, where it is processed into mature miR-155 by cytoplasmic DROSHA, thereby bypassing the XPO5/RAN-GTP blockage via "non-canonical" mechanisms of miRNA biogenesis.

摘要

我们在此报告了 FMS 样酪氨酸激酶 3 内部串联重复(FLT3-ITD)的一个新的促白血病作用,该作用干扰了急性髓系白血病(AML)blasts 中的 microRNAs(miRNAs)生物发生。我们表明,FLT3-ITD 通过磷酸化 SPRED1 蛋白并抑制“守门员”Exportin 5(XPO5)/RAN-GTP 复合物来干扰内含子宿主 miRNA(如 miR-126)的典型生物发生,该复合物调节 pre-miRNAs 的核质转运,以完成成熟为成熟的 miRNAs。值得注意的是,尽管“经典”miRNA 生物发生受阻,但 miR-155 在 FLT3-ITD+AMLblasts 中仍然上调,表明激活了绕过 XPO5/RAN-GTP 阻断的 miRNA 生物发生的替代机制。miR-155 是 BIC-155 长非编码(lnc)RNA 宿主致癌 miRNA,先前已被牵连到 FLT3-ITD+AMLblast 过度增殖中。我们表明,FLT3-ITD 通过抑制 DDX3X 来上调 miR-155,DDX3X 是一种参与 lncRNA 剪接的蛋白质,通过 p-AKT 抑制。DDX3X 的抑制增加了未剪接的 BIC-155,然后由 NXF1 从核转运到细胞质,在细胞质 DROSHA 中加工成成熟的 miR-155,从而绕过 XPO5/RAN-GTP 阻断,通过 miRNA 生物发生的“非经典”机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/ea8e75340b5f/nihms-1666866-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/78987371fe29/nihms-1666866-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/3601840ace75/nihms-1666866-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/86943f2a30db/nihms-1666866-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/5592dc43e408/nihms-1666866-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/7915cb4d0bf0/nihms-1666866-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/afe71fb6ff6d/nihms-1666866-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/ea8e75340b5f/nihms-1666866-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/78987371fe29/nihms-1666866-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/3601840ace75/nihms-1666866-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/86943f2a30db/nihms-1666866-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/5592dc43e408/nihms-1666866-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/7915cb4d0bf0/nihms-1666866-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/afe71fb6ff6d/nihms-1666866-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3e/8973317/ea8e75340b5f/nihms-1666866-f0007.jpg

相似文献

1
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.细胞质 DROSHA 和 FLT3-ITD 急性髓系白血病 miR-155 生物发生的非经典机制。
Leukemia. 2021 Aug;35(8):2285-2298. doi: 10.1038/s41375-021-01166-9. Epub 2021 Feb 15.
2
MicroRNA networks in FLT3-ITD acute myeloid leukemia.FLT3-ITD 急性髓系白血病中的 microRNA 网络。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2112482119. doi: 10.1073/pnas.2112482119. Epub 2022 Apr 11.
3
NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.在FLT3-ITD驱动的急性髓系白血病中,NF-κB/STAT5/miR-155网络靶向PU.1
Leukemia. 2015 Mar;29(3):535-47. doi: 10.1038/leu.2014.231. Epub 2014 Aug 5.
4
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.FLT3 抑制通过 FOXO 上调 HDAC8,使 p53 失活,从而促进 FLT3-ITD+ 急性髓系白血病的维持。
Blood. 2020 Apr 23;135(17):1472-1483. doi: 10.1182/blood.2019003538.
5
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.丝裂原活化蛋白激酶激酶抑制剂 Silvestrol 在体内外均表现出显著的抗白血病活性,并抑制急性髓系白血病中 FLT3 和 miR-155 的表达。
J Hematol Oncol. 2013 Mar 16;6:21. doi: 10.1186/1756-8722-6-21.
6
Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells.异常定位的致癌酪氨酸激酶导致 Ras 激活的特点:FLT3 ITD 在急性髓系白血病细胞的质膜上通过 K-Ras 信号传导。
J Cell Sci. 2013 Oct 15;126(Pt 20):4746-55. doi: 10.1242/jcs.131789. Epub 2013 Aug 13.
7
Shikonin Exerts an Antileukemia Effect against FLT3-ITD Mutated Acute Myeloid Leukemia Cells via Targeting FLT3 and Its Downstream Pathways.紫草素通过靶向 FLT3 及其下游通路对 FLT3-ITD 突变的急性髓系白血病细胞发挥抗白血病作用。
Acta Haematol. 2024;147(3):310-324. doi: 10.1159/000534101. Epub 2023 Nov 3.
8
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD acute myeloid leukemia.PRMT1 介导的 FLT3 精氨酸甲基化促进 FLT3-ITD 急性髓系白血病的维持。
Blood. 2019 Aug 8;134(6):548-560. doi: 10.1182/blood.2019001282. Epub 2019 Jun 19.
9
Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling.天然小分子雷公藤红素通过靶向 Hedgehog/FLT3 信号通路抑制携带 FLT3-ITD 突变的致死性急性髓系白血病。
Biomed Pharmacother. 2021 Jan;133:111054. doi: 10.1016/j.biopha.2020.111054. Epub 2020 Nov 27.
10
Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.致癌性 FLT3-ITD 通过 ATF4 在急性髓系白血病中支持自噬。
Oncogene. 2018 Feb 8;37(6):787-797. doi: 10.1038/onc.2017.376. Epub 2017 Oct 23.

引用本文的文献

1
Association of Variants with Susceptibility and Outcomes in Childhood Acute Lymphoblastic Leukemia.儿童急性淋巴细胞白血病中变异与易感性及预后的关联
Curr Issues Mol Biol. 2025 Jun 19;47(6):473. doi: 10.3390/cimb47060473.
2
BMPMDA: Prediction of MiRNA-Disease Associations Using a Space Projection Model Based on Block Matrix.BMPMDA:基于分块矩阵的空间投影模型预测微小RNA与疾病的关联
Interdiscip Sci. 2023 Mar;15(1):88-99. doi: 10.1007/s12539-022-00542-y. Epub 2022 Nov 6.
3
RNA binding proteins in MLL-rearranged leukemia.MLL重排白血病中的RNA结合蛋白

本文引用的文献

1
The Potential for microRNA Therapeutics and Clinical Research.微小RNA疗法的潜力与临床研究
Front Genet. 2019 May 16;10:478. doi: 10.3389/fgene.2019.00478. eCollection 2019.
2
Targeting FLT3 mutations in AML: review of current knowledge and evidence.AML 中 FLT3 突变的靶向治疗:现有知识和证据的综述。
Leukemia. 2019 Feb;33(2):299-312. doi: 10.1038/s41375-018-0357-9. Epub 2019 Jan 16.
3
The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation.
Exp Hematol Oncol. 2022 Oct 28;11(1):80. doi: 10.1186/s40164-022-00343-5.
4
MicroRNA networks in FLT3-ITD acute myeloid leukemia.FLT3-ITD 急性髓系白血病中的 microRNA 网络。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2112482119. doi: 10.1073/pnas.2112482119. Epub 2022 Apr 11.
5
Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance.靶向 inv(16) 急性髓系白血病中的 miR-126 抑制白血病发生和白血病干细胞维持。
Nat Commun. 2021 Oct 22;12(1):6154. doi: 10.1038/s41467-021-26420-7.
6
Splice and Dice: Intronic microRNAs, Splicing and Cancer.剪接与切割:内含子微小RNA、剪接与癌症
Biomedicines. 2021 Sep 19;9(9):1268. doi: 10.3390/biomedicines9091268.
RNA 解旋酶 DDX17 控制 REST 的转录活性和神经元分化中神经前体 microRNAs 的表达。
Nucleic Acids Res. 2018 Sep 6;46(15):7686-7700. doi: 10.1093/nar/gky545.
4
MicroRNA-155 expression and function in AML: An evolving paradigm.微小RNA-155在急性髓系白血病中的表达与功能:一个不断演变的范例。
Exp Hematol. 2018 Jun;62:1-6. doi: 10.1016/j.exphem.2018.03.007. Epub 2018 Mar 27.
5
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.骨髓龛中小分子 RNA-126 的转移调控慢性髓系白血病中白血病干细胞的自我更新。
Nat Med. 2018 May;24(4):450-462. doi: 10.1038/nm.4499. Epub 2018 Mar 5.
6
A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε.一种 CK1 FRET 生物传感器显示 DDX3X 是 CK1ε 的必需激活剂。
J Cell Sci. 2018 Jan 4;131(1):jcs207316. doi: 10.1242/jcs.207316.
7
NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.神经纤维瘤蛋白募集因子Spred1的EVH1结构域的核磁共振共振归属
Biomol NMR Assign. 2017 Oct;11(2):305-308. doi: 10.1007/s12104-017-9768-1. Epub 2017 Aug 22.
8
MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.微小RNA与急性髓系白血病:治疗意义及新观点
Blood. 2017 Sep 14;130(11):1290-1301. doi: 10.1182/blood-2016-10-697698. Epub 2017 Jul 27.
9
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.米哚妥林联合化疗治疗伴有FLT3突变的急性髓系白血病
N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.
10
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.微小RNA-155通过抑制干扰素反应促进FLT3-ITD诱导的骨髓增殖性疾病。
Blood. 2017 Jun 8;129(23):3074-3086. doi: 10.1182/blood-2016-09-740209. Epub 2017 Apr 21.